Informative Exhibition for Deprescribing Benzodiazepines

Benzodiazepine-Related Disorders Clinical Trial

— ESUB  

Official title:

Impact of an Interactive and Informative Exhibition on Benzodiazepine Use on Deprescription.

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT06467019
• Other study ID #: CSAPG-59
• Status: Recruiting
• Start date: June 13, 2024
• Est. completion date: July 2025

Study information

• Verified date: April 2024
• Source: Consorci Sanitari de l'Alt Penedès i Garraf
• Contact: Jordi Milozzi, MD
• Phone: +34 938 10 30 03
• Email: jmilozzi[@]csapg.cat
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The goal of this trial is to determine if an interactive and informative exhibition in the waiting room of a Primary Care Clinic can reduce the use of benzodiazepines in adults. The main question it aims to answer is:

• Does an interactive and informative exhibition reduce the number of participants using benzodiazepines? Researchers will compare benzodiazepine consumption before and after the interactive and informative exhibition implementation at study center.

Participants will receive an informative and interactive exhibition on the risks of chronic benzodiazepine use. A single informative session on the same topic will be conducted for health professionals.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 6410
• Est. completion date: July 2025
• Est. primary completion date: July 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 99 Years

Eligibility

Inclusion Criteria:

• Men and women between 18 and 99 years of age.

• Attended at the Baix-a-Mar Primary Care Center during the study period.

Exclusion Criteria:

• Severe mental health disease

• Displaced patients or those who do not have an assigned doctor at the center.

• Participation in another study involving an experimental intervention during the period of the present study that affects benzodiazepine prescription.

Related Conditions & MeSH terms

• Benzodiazepine-Related Disorders

Intervention

Other:
• Informative Session
The intervention consists of implementing an interactive exhibition on the risks of chronic benzodiazepine treatment in the waiting room of a primary care center. Additionally, the health professionals at the center will receive a single informative session on the same topic.

Locations

Country	Name	City	State
Spain	Centro de Salud Vilanova i la Geltrú 3 Baix A Mar	Vilanova I La Geltrú	Barcelona

Sponsors (1)

Lead Sponsor	Collaborator
Consorci Sanitari de l'Alt Penedès i Garraf

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Chronic treatment with benzodiazepines	Percentage of patients treated chronically with benzodiazepines at pre-intervention and at months 1, 6, and 12 post-intervention, based on electronic prescription data.	1 year